Literature DB >> 6644576

Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.

S G Frank, D R Kavaliunas.   

Abstract

The formation of an inclusion compound by beta-cyclodextrin with hydrocortisone has been studied by proton magnetic resonance (1H-NMR) and phase solubility analysis. The magnitude of the chemical shifts of the interior and exterior beta-cyclodextrin protons in the presence of hydrocortisone indicated that hydrocortisone is included within the beta-cyclodextrin cavity and probably interacts with protons on the edge of the torus. The overall stoichiometry of the inclusion compound was not a single, simple relationship, but was unusual in that it was variable and apparently dependent on the relative amounts of hydrocortisone and beta-cyclodextrin in the system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644576     DOI: 10.1002/jps.2600721028

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Effect of sulfated beta-cyclodextrin, a water soluble cycloamylose, on the promotion and/or inhibition of angiogenesis.

Authors:  Laura Strauss; Marcela Fuenzalida; Julio Illanes; Alfredo Dabancens; Eugenia Díaz; David Lemus; Anibal Guerrero
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

2.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

3.  Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion.

Authors:  Mohammad A Altamimi; Ehab M Elzayat; Wajhul Qamar; Sultan M Alshehri; Abdelrahman Y Sherif; Nazrul Haq; Faiyaz Shakeel
Journal:  Saudi Pharm J       Date:  2019-03-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.